Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,641 to 1,660 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatoprotective agent tethered isoniazid for the treatment of drug-induced hepatotoxicity: Synthesis, biochemical and histopathological evaluation. | Toxicol Rep | 2014 | 28962300 | PubTator, text mining | PubMed |
| Correlation of antituberculosis drug-related liver injury and liver function monitoring: A 12-year experience of the Taiwan Drug Relief Foundation. | J Food Drug Anal | 2014 | 28911426 | PubTator, text mining | PubMed |
| NAT2 genetic variations among South Indian populations. | Hum Genome Var | 2014 | 27081506 | PubTator, text mining | PubMed |
| Developmental Immunotoxicity, Perinatal Programming, and Noncommunicable Diseases: Focus on Human Studies. | Adv Med | 2014 | 26556429 | PubTator, text mining | PubMed |
| Impact of urinary bladder cancer risk variants on prognosis and survival. | EXCLI J | 2014 | 26417338 | PubTator, text mining | PubMed |
| Arylamine N-acetyl Transferase (NAT) in the blue secretion of Telescopium telescopium: xenobiotic metabolizing enzyme as a biomarker for detection of environmental pollution. | Springerplus | 2014 | 26034680 | PubTator, text mining | PubMed |
| A homogenizing process of selection has maintained an "ultra-slow" acetylation NAT2 variant in humans. | Hum Biol | 2014 | 25836746 | PubTator, text mining | PubMed |
| [Role of gene polymorphisms of phase II of xenobiotic biotransformation from glutathione-S-transferase and N-acetyltransferase families in susceptibility to lung cancer among Mayak workers]. | Radiats Biol Radioecol | 2014 | 25775823 | PubTator, text mining | PubMed |
| NAT2 gene polymorphisms in three indigenous groups in the Colombian Caribbean Coast region. | Colomb Med (Cali) | 2014 | 25767302 | PubTator, text mining | PubMed |
| Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population. | BMC Genet | 2014 | 25544508 | PubTator, text mining | PubMed |
| Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. | BMC Cancer | 2014 | 25528056 | PubTator, text mining | PubMed |
| Genomic architecture of pharmacological efficacy and adverse events. | Pharmacogenomics | 2014 | 25521360 | PubTator, text mining | PubMed |
| Identification of a novel heterozygous truncation mutation in exon 1 of ARHGAP29 in an Indian subject with nonsyndromic cleft lip with cleft palate. | Eur J Dent | 2014 | 25512736 | PubTator, text mining | PubMed |
| Genetic polymorphisms in metabolic enzymes and susceptibility to anti-tuberculosis drug-induced hepatic injury. | Genet Mol Res | 2014 | 25501156 | PubTator, text mining | PubMed |
| Pharmacogenomics of antimicrobial agents. | Pharmacogenomics | 2014 | 25495412 | PubTator, text mining | PubMed |
| Smoking and rheumatoid arthritis. | Int J Mol Sci | 2014 | 25479074 | PubTator, text mining | PubMed |
| DNA methylation modifies urine biomarker levels in 1,6-hexamethylene diisocyanate exposed workers: a pilot study. | Toxicol Lett | 2014 | 25445006 | PubTator, text mining | PubMed |
| Genetics, environment, and gene-environment interactions in the development of systemic rheumatic diseases. | Rheum Dis Clin North Am | 2014 | 25437282 | PubTator, text mining | PubMed |
| Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding. | BMC Pharmacol Toxicol | 2014 | 25432241 | PubTator, text mining | PubMed |
| Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region. | Asian Pac J Cancer Prev | 2014 | 25422202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=83